Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2000 Aug 14;1(3):69–78. doi: 10.1208/pt010324

Effect of carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels

Yvonne T F Tan 1, Kok Khiang Peh 1, Othman Al-Hanbali 1
PMCID: PMC2750352  PMID: 14727910

Abstract

This study examined the mechanical (hardness, compressibility, adhesiveness, and cohesiveness) and rheological (zero-rate viscosity and thixotropy) properties of polyethylene glycol (PEG) gels that contain different ratios of Carbopol 934P (CP) and polyvinylpyrrolidone K90 (PVP). Mechanical properties were examined using a texture analyzer (TA-XT2), and rheological properties were examined using a rheometer (Rheomat 115A). In addition, lidocaine release from gels was evaluated using a release apparatus simulating the buccal condition. The results indicated that an increase in CP concentration significantly increased gel compressibility, hardness, and adhesiveness, factors that affect ease of gel removal from container, ease of gel application onto mucosal membrane, and gel bioadhesion. However, CP concentration was negatively correlated with gel cohesiveness, a factor representing structural reformation. In contrast, PVP concentration as negatively correlated with gel hardness and compressibility, but positively correlated with gel cohesiveness. All PEG gels exhibited pseudoplastic flow with thixotropy, indicating a general loss of consistency with increased shearing stress. Drug release T50% was affected by the flow rate of the simulated saliva solution. A reduction in the flow rate caused a slower drug release and hence a higher T50% value. In addition, drug release was significantly reduced as the concentrations of CP and PVP increased because of the increase in zero-rate viscosity of the gels. Response surfaces and contour plots of the dependent variables further substantiated that various combinations of CP and PVP in the PEG gels offered a wide range of mechanical, rheological, and drug-release characteristics. A combination of CP and PVP with complementary physical properties resulted in a prolonged buccal drug delivery.

Keywords: Bioadhesion, Mechanical properties, Rheological properties, Drug release, Carbopol, Polyvinylpyrrolidone

Full Text

The Full Text of this article is available as a PDF (741.3 KB).

References

  • 1.Bodde HE, De Vries ME, Junginger HE. Mucoadhesive polymers for the buccal delivery of peptides, structure-adhesiveness relationships. J Control Rel. 1990;13:225–231. doi: 10.1016/0168-3659(90)90012-I. [DOI] [Google Scholar]
  • 2.Rathbone MJ, Hadgraft J. Absorption of drugs from the human oral cavity. Int J Pharm. 1991;74:9–24. doi: 10.1016/0378-5173(91)90403-B. [DOI] [Google Scholar]
  • 3.Squier CA. The permeability of oral mucosa. Crit Rev Oral Biol Med. 1991;2:13–32. doi: 10.1177/10454411910020010301. [DOI] [PubMed] [Google Scholar]
  • 4.De Vries ME, Bodde HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Rev Ther Drug Carr Sys. 1991;8:271–303. [PubMed] [Google Scholar]
  • 5.Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998;1(1):15–30. [PubMed] [Google Scholar]
  • 6.Jones DS, Woolfson AD, Brown AF. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res. 1997;114(4):450–457. doi: 10.1023/A:1012091231023. [DOI] [PubMed] [Google Scholar]
  • 7.Sveinsson SJ, Holbrook WP. Oral mucosal adhesive ointment containing liposomal corticosteroid. Int J Pharm. 1993;95:105–109. doi: 10.1016/0378-5173(93)90396-W. [DOI] [Google Scholar]
  • 8.Sugawara S, Imai T, Otagiri M. The controlled release of prednisolone using alginate gel. Pharm Res. 1994;11(2):272–277. doi: 10.1023/A:1018963626248. [DOI] [PubMed] [Google Scholar]
  • 9.Amin PD, Fruitwala PD. Erythromycin gel-a topical anti-acne preparation. Drug Dev Ind Pharm. 1994;20(7):1309–1316. doi: 10.3109/03639049409038371. [DOI] [Google Scholar]
  • 10.Mumtaz AM, Ch’ng HS. Design of a dissolution apparatus suitable for in situ release study of triamcinolone acetonide from bioadhesive buccal tablets. Int J Pharm. 1995;121:129–139. doi: 10.1016/0378-5173(94)00406-U. [DOI] [Google Scholar]
  • 11.Ishida M, Machida Y, Nambu N, Nagai T. New mucosal dosage form of insulin. Chem Pharm Bull. 1981;29:810–816. doi: 10.1248/cpb.29.810. [DOI] [PubMed] [Google Scholar]
  • 12.Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm. 1984;19:107–127. doi: 10.1016/0378-5173(84)90154-6. [DOI] [Google Scholar]
  • 13.Satoh K, Takayama K, Machida Y, Suzuki Y, Nakagaki M, Nagai T. Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. Chem Pharm Bull. 1989;37:1366–1368. doi: 10.1248/cpb.37.1366. [DOI] [PubMed] [Google Scholar]
  • 14.Anlar S, Capan Y, Guven O, Gogus A, Dlakara T, Hincal AA. Formulation and in-vitro evaluation of buccoadhesive morphine sulfate tablets. Pharm Res. 1994;11:231–236. doi: 10.1023/A:1018951323522. [DOI] [PubMed] [Google Scholar]
  • 15.Guo JH. Investigating the surface properties and bioadhesion of buccal patches. J Pharm Pharmacol. 1994;46:647–650. doi: 10.1111/j.2042-7158.1994.tb03875.x. [DOI] [PubMed] [Google Scholar]
  • 16.Nakane S, Kakumoto M, Yukimatsu K, Chien YW. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm Dev Tech. 1996;1:251–259. doi: 10.3109/10837459609022593. [DOI] [PubMed] [Google Scholar]
  • 17.Nozaki Y, Ohta M, Chien YW. Transmucosal controlled systemic delivery of isosorbide dinitrate: in vivo/ in vitro correlation. J Control Rel. 1997;43:105–114. doi: 10.1016/S0168-3659(96)01485-X. [DOI] [Google Scholar]
  • 18.Jones DS, Woolfson AD, Djokic J, Irwin CR. Bioadhesive, semi-solid systems containing flurbiprofen for the treatment of gingivitis. Eur J Pharm Sci. 1996;4(1):S145–S145. doi: 10.1016/S0928-0987(97)86433-0. [DOI] [PubMed] [Google Scholar]
  • 19.Jones DS, Woolfson AD, Brown AF, O’Neill MJ. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J Control Rel. 1997;49(1):71–79. doi: 10.1016/S0168-3659(97)00060-6. [DOI] [Google Scholar]
  • 20.Aungst BJ, Rogers NJ. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm. 1989;53:227–235. doi: 10.1016/0378-5173(89)90316-5. [DOI] [Google Scholar]
  • 21.Siegel IA, Izutsu KT, Watson E. Mechanisms of non-electrolyte penetration across dog and rabbit oral mucosa in vitro. Arch Oral Biol. 1981;26:357–361. doi: 10.1016/0003-9969(81)90030-3. [DOI] [PubMed] [Google Scholar]
  • 22.Coutel-Egros A, Maitani Y, Veillard M, Machida Y, Nagai T. Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch. Int J Pharm. 1992;84:117–128. doi: 10.1016/0378-5173(92)90052-4. [DOI] [Google Scholar]
  • 23.Hoogstraate AJ, Senel S, Cullander C, Verhoef J, Junginger HE, Bodde HE. Effects of bile salts on transport rates and routes of FTIC-labelled model compounds across porcine buccal epithelium in vitro. J Control Rel. 1996;40:211–221. doi: 10.1016/0168-3659(95)00187-5. [DOI] [Google Scholar]
  • 24.Mehta M, Kemppainen BW, Stafford RG. In vitro penetration of tritium-labelled water (THO) and [3H]PbTx-3 (a red tide toxin) through monkey buccal mucosa and skin. Tox Lett. 1991;55:185–194. doi: 10.1016/0378-4274(91)90133-Q. [DOI] [PubMed] [Google Scholar]
  • 25.Wilson CG, Washington N. Physiological pharmaceutics biological barriers to drug absorption. Chichester, UK: Ellis Horwood Ltd., John Wiley & Sons; 1989. [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES